nivolumab
bms
['biomarker']
3/ ricketts_immunosuppression genomic signature correlated with early pathologic response to ici (auc=0.76, p=0.01). potential biomarker for ici-sensitive tumor subtypes. #aacr23 #precisionmedicine
Radiation Oncology Resident @MoffittRadOnc // @ARRO_org Communications Subcommittee // Husband + Girl Dad